Showing 12,121 - 12,140 results of 31,515 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((fold decrease) OR (nn decrease)) ))', query time: 0.93s Refine Results
  1. 12121
  2. 12122
  3. 12123

    The health care utilization of people in prison and after prison release: A population-based cohort study in Ontario, Canada by Fiona G. Kouyoumdjian (489495)

    Published 2018
    “…<div><p>Background</p><p>Many people experience imprisonment each year, and this population bears a disproportionate burden of morbidity and mortality. …”
  4. 12124

    Data Sheet 1_Efficacy and safety of hydroxyurea therapy on patients with β-thalassemia: a systematic review and meta-analysis.pdf by Tianmin Huang (20561477)

    Published 2025
    “…HU, in transfusion-dependent β-thalassemia patients, was related to a significant decrease in transfusion requirements [a pooled RR of 0.37 and a pooled good RR of 0.65 (95% CI, 0.53–0.76)]; in transfusion-independent β-thalassemia patients, it was correlated to an excellent raise in Hb levels [a pooled RR of 0.20 (95% CI, 0.08–0.35) and a pooled good RR of 0.53 (95% CI, 0.41–0.65)]. …”
  5. 12125

    The rescue intervention strategy for asthma patients under severe air pollution: a single-center prospective randomized controlled trial by Xiaoyu Yang (547580)

    Published 2022
    “…</p> <p>A novel strategy to administer treatment at the first signs of severe air pollution and before patients experience symptoms may decrease the risk of asthma exacerbations and negative outcomes under severe air pollution conditions.…”
  6. 12126

    DataSheet1_Prognostic value of oxygen inhalation therapy for simple nocturnal hypoxemia in COPD: a meta-analysis.pdf by Ling Sun (301114)

    Published 2023
    “…The publication bias and heterogeneity of the included studies were evaluated.</p><p>Results: A total of 621 patients from 5 studies were included in this meta-analysis, and there was no publication bias in the included studies. …”
  7. 12127

    Data Sheet 3_Efficacy and safety of hydroxyurea therapy on patients with β-thalassemia: a systematic review and meta-analysis.pdf by Tianmin Huang (20561477)

    Published 2025
    “…HU, in transfusion-dependent β-thalassemia patients, was related to a significant decrease in transfusion requirements [a pooled RR of 0.37 and a pooled good RR of 0.65 (95% CI, 0.53–0.76)]; in transfusion-independent β-thalassemia patients, it was correlated to an excellent raise in Hb levels [a pooled RR of 0.20 (95% CI, 0.08–0.35) and a pooled good RR of 0.53 (95% CI, 0.41–0.65)]. …”
  8. 12128

    Effect of dipeptidyl peptidase-4 inhibitors on cisplatin-induced acute nephrotoxicity in cancer patients with diabetes mellitus: A retrospective study by Takamasa Iwakura (798461)

    Published 2020
    “…<div><p>Background</p><p>Cisplatin is a highly effective chemotherapeutic agent. However, acute kidney injury (AKI) limits its subsequent use, resulting in poor cancer prognosis. …”
  9. 12129

    Data Sheet 2_Efficacy and safety of hydroxyurea therapy on patients with β-thalassemia: a systematic review and meta-analysis.pdf by Tianmin Huang (20561477)

    Published 2025
    “…HU, in transfusion-dependent β-thalassemia patients, was related to a significant decrease in transfusion requirements [a pooled RR of 0.37 and a pooled good RR of 0.65 (95% CI, 0.53–0.76)]; in transfusion-independent β-thalassemia patients, it was correlated to an excellent raise in Hb levels [a pooled RR of 0.20 (95% CI, 0.08–0.35) and a pooled good RR of 0.53 (95% CI, 0.41–0.65)]. …”
  10. 12130

    Image_1_Long-Term Increase in Cholesterol Is Associated With Better Cognitive Function: Evidence From a Longitudinal Study.TIF by Huamin Liu (6852678)

    Published 2021
    “…</p><p>Methods: A total of 4,915 participants aged ≥45 years with normal cognition in baseline were included. …”
  11. 12131
  12. 12132
  13. 12133
  14. 12134
  15. 12135
  16. 12136
  17. 12137
  18. 12138
  19. 12139
  20. 12140